ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software
May 18, 2021 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing navigation and delivery to the brain, today...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’
May 11, 2021 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room
May 10, 2021 17:21 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021
April 29, 2021 16:38 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro, Inc. Congratulates Voyager Therapeutics on FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease
April 28, 2021 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr.
April 13, 2021 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
April 06, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel
March 24, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results
March 04, 2021 16:05 ET | ClearPoint Neuro, Inc.
Company Reports Record Revenues IRVINE, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021
February 19, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...